- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04203602
Hospital Discharge Following Bariatric Surgery by Telepresence Robot
Assessment of Feasibility and Efficacy of Hospital Discharge Following Bariatric Surgery Using a Telepresence Robot: a Non-inferiority Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is aimed to analyze the effectiveness and feasibility of performing the ward round using a telepresence robot (PadBot U, Inbot Technology Ltd, China), compared to the face-to-face ward round, for hospital discharge after bariatric surgery. Patients who underwent either laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy will be randomized to one of two groups: intervention group - who will be evaluated and discharged, on postoperative day (POD) 2, during ward rounds with the assistant team present, but the telepresent surgeon via robot; and control group - who will be evaluated and discharged, on POD 2, during ward rounds with the whole team physically present.
The study main hypothesis is that the ward rounds with the surgeon telepresent by a robot are not inferior to the face to face ward rounds, to evaluate and discharge patients after bariatric surgery.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Guilherme S Mazzini, MD, PhD
- Phone Number: +55(51)982364873
- Email: guimazzini@gmail.com
Study Locations
-
-
RS
-
Montenegro, RS, Brazil
- Recruiting
- Unimed Vale do Caí
-
Contact:
- Cacio R Wietzycoski, MD
- Phone Number: +55(51)991719499
- Email: wiezycoski@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients that underwent bariatric surgery (either laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy
Exclusion Criteria:
- complications during surgery; unable to sign informed consent; admitted to ICU; previous foregut surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telepresence round
Patients will be seen during ward rounds by the multidisciplinary team physically present, but with the surgeon remotely present via a telepresence robot.
|
Patients will be seen during ward rounds by the multidisciplinary team physically present, but with the surgeon remotely present via a telepresence robot.
|
Active Comparator: conventional round
Patients will be seen during ward rounds by the whole multidisciplinary team physically present, including the surgeon.
|
Patients will be seen during ward rounds by the whole multidisciplinary team physically present, including the surgeon.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital discharges by robotic or face-to-face rounds
Time Frame: 2 days
|
number of patients discharged on postoperative day 2 by robotic or face-to-face ward rounds
|
2 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
contact with team
Time Frame: 2 weeks
|
number of phone calls to the assistant team after discharge and before first visit at the clinic
|
2 weeks
|
complications, reoperations, readmissions
Time Frame: up to 30 days after surgery
|
rates of early complications, reoperations, readmissions
|
up to 30 days after surgery
|
Patients' and team's impressions
Time Frame: 2 days
|
compare a validated questionnaire design to access patients' and team's impressions.
There are 13 questions with answers valued from 1 to 5. The higher the score, the better the impression.
The scores from the two groups are going to be compared in order to determine if patients' and team's impressions are similar with either robotic or face-to-face rounds.
|
2 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Guilherme S Mazzini, MD, PhD, Hospital de Clinicas de Porto Alegre
- Study Director: Cacio Wietzycoski, MD, Hospital Unimed Vale do Caí
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25656919.4.0000.5327
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Obesity
-
University of California, San FranciscoCompletedClinically Severe ObesityUnited States
-
Nantes University HospitalCompletedSevere Obesity Design as BMI > 35kg/m2France
-
University of California, San FranciscoCompletedClinically Severe Obesity | Weight Regain | Obesity Recidivism | Weight RecidivismUnited States
-
University of California, San FranciscoCompletedClinically Severe Obesity | Inadequate Weight Loss | Obesity RecidivismUnited States
-
University of California, San FranciscoCompletedInadequate Initial Weight Loss | Persistent Clinically Severe ObesityUnited States
-
University of California, San FranciscoCompletedClinically Severe Obesity | Protein Malnutrition | Obesity Recidivism | Metabolic Complications After Jejunoileal Bypass | Nutritional Complications After Jejunoileal Bypass | Inadequate Initial Weight Loss | Intestinal Malabsorptive SyndromeUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Shanghai Jiao Tong University School of MedicineUnknown
Clinical Trials on telepresence discharge
-
Association APPROCHELP3C, University of Rennes 2; COVEARecruitingMotor Disorders | Cognitive DisabilityFrance
-
Gérond'ifRecruitingElderly People Living at Home | With an Internet Connection at HomeFrance
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationNot yet recruiting
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Glasgow Royal InfirmaryNot yet recruiting
-
Lahey ClinicCompletedOff-shift Robotic TeleroundingUnited States
-
Centre Leon BerardRecruiting
-
Barretos Cancer HospitalCompleted
-
Ward of the 21st CenturyCanadian Institutes of Health Research (CIHR); Alberta Health services; University...CompletedOther Diagnoses, Comorbidities, and ComplicationsCanada
-
Kamil NovobílskýCompletedCoronary Artery Disease | Primary Percutaneous Coronary Intervention | Early Discharge | Acute Myocardial Infarction With ST-segment ElevationCzechia
-
Fundació Institut de Recerca de l'Hospital de la...UnknownMyocardial InfarctionSpain